Peter Morgan Kash

Paramount BioCapital, Inc. is an alternative investment manager. The private company is based in New York, NY and has subsidiaries in the United States.

Founded in 1991 by Dr. Lindsay Rosenwald, Paramount BioCapital Asset Management, Inc. is a hedge fund manager located in New York City. The firm is a subsidiary of Paramount BioCapital, Inc.

Part of Two River Group Holdings LLC, Riverbank Capital Securities, Inc. deals securities. The private company is based in New York, NY.

Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY.

Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA.

Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL.

Andorra International, Inc. formulates, and manufactures and distributes dietary supplements. The firm offers Resveratrol, Caviar Omega, CholesteRight, Advanced Blood and Advanced Liver Detox products. The company was founded by Michelle Sun and Peter M. Kash in 2015 and is headquartered in Los Angeles, CA.

Targimmune Therapeutics AG engages in the drug development using novel targeted onco-immunotherapies. The company was founded by Andreas Emmenegger and Peter Kash and is headquartered in Basel, Switzerland.

Healthcare Capital Corp. operates as a blank check company. It engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on August 18, 2020 and is headquartered in Wilmington, DE.

FFD, Inc. provides manufacturing software solutions. The private company is based in Knoxville, TN.

Part of Swedish Orphan Biovitrum AB, PolaRx Biopharmaceuticals is a private company that manufactures TriOxide drugs for the treatment of leukemia and other cancers. The company is based in New York, NY. The company was founded by Fred H. Mermelstein, Peter Morgan Kash, Raymond P. Warrell. PolaRx Biopharmaceuticals was acquired by CTI BioPharma Corp., part of Swedish Orphan Biovitrum AB from June 27, 2023 on January 13, 2000 for $17.50 million.

Part of GSK Plc, ID Vaccine Corp. develops gene-based disease testing and subunit vaccines.